| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Equity |
99.86 |
| Trep |
0.14 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
38.92% |
| Top 10 Holdings |
61.50% |
| Top 25 Holdings |
93.75% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
77.96 |
| Healthcare |
21.9 |
| Cash |
0.14 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.81 |
| PE Ratio |
38.24 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Lupin Limited |
10.67 |
| Fortis Health Care Ltd |
7.88 |
| Laurus Labs Limited |
7.34 |
| Aurobindo Pharma Limited |
6.93 |
| Glenmark Pharmaceuticals Limited |
6.10 |
| Alkem Laboratories Limited |
5.90 |
| Biocon Limited |
4.90 |
| Mankind Pharma Limited |
4.32 |
| IPCA Laboratories Limited |
4.23 |
| Aster DM Healthcare Limited |
3.23 |
| J B Chemicals and Pharma Ltd |
3.21 |
| Krishna Inst of Medical Sciences Ltd. |
2.92 |
| Gland Pharma Limited |
2.57 |
| Abbott India Limited |
2.56 |
| Sai Life Sciences Limited |
2.54 |
| Ajanta Pharma Limited |
2.25 |
| Narayana Hrudalaya Ltd |
2.11 |
| Neuland Laboratories Limited |
1.97 |
| Dr Lal Path Labs Ltd |
1.94 |
| Wockhardt Limited |
1.85 |
| Glaxosmithkline Pharma Ltd |
1.80 |
| Granules India Limited |
1.71 |
| Natco Pharma Limited |
1.66 |
| Piramal Pharma Limited |
1.61 |
| EQ- GLOBAL HEALTH LTD. |
1.55 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|